id	sid	eid	entity	type
admet-2357	1	1	avanafil	ORG
admet-2357	1	2	https://doi.org/10.5599/admet.2357 529 admet	ORG
admet-2357	1	3	2024	CARDINAL
admet-2357	1	4	529-542	CARDINAL
admet-2357	2	1	issn	PERSON
admet-2357	2	2	1848-7718	DATE
admet-2357	2	3	avanafil	ORG
admet-2357	2	4	saadi ali1	PERSON
admet-2357	2	5	a. h. barzani2	PERSON
admet-2357	2	6	yavuz yardım*,3 1department	ORG
admet-2357	2	7	van yuzuncu yil university	ORG
admet-2357	2	8	65080	CARDINAL
admet-2357	2	9	turkey	GPE
admet-2357	2	10	2department	TIME
admet-2357	2	11	lebanese	NORP
admet-2357	2	12	french	NORP
admet-2357	2	13	erbil	GPE
admet-2357	2	14	iraq	GPE
admet-2357	3	1	3department	CARDINAL
admet-2357	3	2	van yuzuncu yil university	ORG
admet-2357	3	3	65080	CARDINAL
admet-2357	3	4	4322251308	DATE
admet-2357	3	5	4322167519	DATE
admet-2357	3	6	march 2, 2024	DATE
admet-2357	3	7	june 19, 2024	DATE
admet-2357	3	8	june 27	DATE
admet-2357	3	9	2024	DATE
admet-2357	3	10	avanafil	ORG
admet-2357	3	11	avn	PERSON
admet-2357	5	1	bdd	ORG
admet-2357	6	1	britton-robinson	ORG
admet-2357	6	2	0.04 mol l-1	QUANTITY
admet-2357	6	3	4.0	CARDINAL
admet-2357	9	1	0.04 mol l-1	QUANTITY
admet-2357	9	2	+1.33	GPE
admet-2357	10	1	0.5	CARDINAL
admet-2357	10	2	1.0	CARDINAL
admet-2357	10	3	62	CARDINAL
admet-2357	10	4	µmol l-1	PERSON
admet-2357	10	5	0.14 μg ml-1	QUANTITY
admet-2357	11	1	0.29	CARDINAL
admet-2357	12	1	avn	PERSON
admet-2357	15	1	2024	CARDINAL
admet-2357	17	1	1	CARDINAL
admet-2357	18	1	an estimated	CARDINAL
admet-2357	18	2	5-20 %	PERCENT
admet-2357	19	1	avanafil	ORG
admet-2357	19	2	avn	PERSON
admet-2357	20	1	avn	PERSON
admet-2357	20	2	2	CARDINAL
admet-2357	21	1	1 https://doi.org/10.5599/admet.2357 https://doi.org/10.5599/admet.2357	QUANTITY
admet-2357	22	1	h. s. ali et al. admet	PERSON
admet-2357	22	2	2024	CARDINAL
admet-2357	22	3	529-542 530	QUANTITY
admet-2357	22	4	3	CARDINAL
admet-2357	24	1	the european medicines	ORG
admet-2357	24	2	ema	ORG
admet-2357	24	3	2013	DATE
admet-2357	24	4	the united states	GPE
admet-2357	24	5	food and drug administration	ORG
admet-2357	24	6	fda	ORG
admet-2357	24	7	2012	DATE
admet-2357	25	1	avn	PERSON
admet-2357	27	1	avn	PERSON
admet-2357	28	1	38 to 41 %	PERCENT
admet-2357	28	2	4	CARDINAL
admet-2357	29	1	5	CARDINAL
admet-2357	30	1	müller	PERSON
admet-2357	30	2	2008	DATE
admet-2357	31	1	6	CARDINAL
admet-2357	33	1	three	CARDINAL
admet-2357	33	2	8-13	CARDINAL
admet-2357	33	3	14	CARDINAL
admet-2357	33	4	15-19	CARDINAL
admet-2357	34	1	20	CARDINAL
admet-2357	35	1	21	CARDINAL
admet-2357	36	1	the past twenty years	DATE
admet-2357	36	2	bdd	ORG
admet-2357	37	1	24	CARDINAL
admet-2357	38	1	bdd	ORG
admet-2357	39	1	bdd	ORG
admet-2357	39	2	24,28,32,33	CARDINAL
admet-2357	40	1	only three	CARDINAL
admet-2357	40	2	avn	PERSON
admet-2357	42	1	first	ORDINAL
admet-2357	43	1	avn	PERSON
admet-2357	45	1	®	ORG
admet-2357	45	2	98.0 %	PERCENT
admet-2357	45	3	chemscene llc (usa	ORG
admet-2357	47	1	pbs	ORG
admet-2357	47	2	0.1 mol l-1	QUANTITY
admet-2357	47	3	0.1 mol l-1	QUANTITY
admet-2357	48	1	2 to 12	DATE
admet-2357	48	2	germany	GPE
admet-2357	49	1	avn	PERSON
admet-2357	49	2	0.1 mol l-1 hci	QUANTITY
admet-2357	49	3	1.0 mg	QUANTITY
admet-2357	50	1	4 °	QUANTITY
admet-2357	52	1	2024	CARDINAL
admet-2357	52	2	529	CARDINAL
admet-2357	52	3	avanafil	ORG
admet-2357	52	4	531	CARDINAL
admet-2357	52	5	b.v.	GPE
admet-2357	52	6	utrecht	GPE
admet-2357	52	7	netherlands	GPE
admet-2357	52	8	4.9	CARDINAL
admet-2357	54	1	0.01	CARDINAL
admet-2357	54	2	three	CARDINAL
admet-2357	54	3	windsor scientific ltd.	ORG
admet-2357	54	4	3 mm	QUANTITY
admet-2357	54	5	1000 ppm	QUANTITY
admet-2357	54	6	3 mol l-1 nacl	QUANTITY
admet-2357	54	7	bas	GPE
admet-2357	54	8	mw-4130	DATE
admet-2357	55	1	25 °	QUANTITY
admet-2357	55	2	wtw	CARDINAL
admet-2357	55	3	germany	GPE
admet-2357	56	1	34	CARDINAL
admet-2357	57	1	bdd	PRODUCT
admet-2357	57	2	35	CARDINAL
admet-2357	58	1	each day	DATE
admet-2357	58	2	cpt	ORG
admet-2357	58	3	0.5	CARDINAL
admet-2357	59	1	1.8	CARDINAL
admet-2357	61	1	0.036 cm²	QUANTITY
admet-2357	61	2	38	CARDINAL
admet-2357	62	1	less than a minute	TIME
admet-2357	64	1	avn	PERSON
admet-2357	64	2	bdd	ORG
admet-2357	64	3	cv	ORG
admet-2357	66	1	swv.	GPE
admet-2357	67	1	swv	PERSON
admet-2357	67	2	three	CARDINAL
admet-2357	68	1	0	CARDINAL
admet-2357	68	2	1.60	CARDINAL
admet-2357	68	3	avn	PERSON
admet-2357	68	4	12	CARDINAL
admet-2357	68	5	60	CARDINAL
admet-2357	68	6	50	CARDINAL
admet-2357	70	1	ae lab guangzhou co., ltd	ORG
admet-2357	70	2	china	GPE
admet-2357	70	3	1 cm	QUANTITY
admet-2357	71	1	0.1	CARDINAL
admet-2357	71	2	mol l-1 hcl	PERSON
admet-2357	71	3	200 to 800	CARDINAL
admet-2357	72	1	245	CARDINAL
admet-2357	73	1	100	CARDINAL
admet-2357	73	2	avn	PERSON
admet-2357	74	1	ten	CARDINAL
admet-2357	75	1	5.0 mg avn	QUANTITY
admet-2357	75	2	50 ml	QUANTITY
admet-2357	75	3	0.1 mol l-1 hcl	QUANTITY
admet-2357	76	1	around 5 min	TIME
admet-2357	77	1	100	CARDINAL
admet-2357	77	2	h. s. ali et al	PERSON
admet-2357	77	3	2024	CARDINAL
admet-2357	77	4	542 532	CARDINAL
admet-2357	77	5	0.04 mol l-1	QUANTITY
admet-2357	78	1	1	CARDINAL
admet-2357	78	2	2.5	CARDINAL
admet-2357	78	3	5	DATE
admet-2357	78	4	10	DATE
admet-2357	78	5	15	DATE
admet-2357	78	6	20 μg	QUANTITY
admet-2357	79	1	avn	PERSON
admet-2357	81	1	33-year-old	DATE
admet-2357	82	1	9.0 ml	QUANTITY
admet-2357	82	2	1.0 ml	QUANTITY
admet-2357	82	3	1.0 mg	QUANTITY
admet-2357	83	1	1 min	TIME
admet-2357	83	2	0.05 ml	QUANTITY
admet-2357	83	3	10 ml	QUANTITY
admet-2357	83	4	0.04 mol l-1	QUANTITY
admet-2357	84	1	avn	PERSON
admet-2357	86	1	cv	ORG
admet-2357	86	2	three	CARDINAL
admet-2357	86	3	cv	ORG
admet-2357	86	4	50 μg ml-1 avn	QUANTITY
admet-2357	86	5	0.04 mol l-1	QUANTITY
admet-2357	86	6	0	CARDINAL
admet-2357	86	7	1.70	CARDINAL
admet-2357	86	8	100	CARDINAL
admet-2357	87	1	first	ORDINAL
admet-2357	87	2	avn	PERSON
admet-2357	87	3	approximately 1.44	CARDINAL
admet-2357	87	4	1a	CARDINAL
admet-2357	88	1	avn	PERSON
admet-2357	89	1	avn	PERSON
admet-2357	90	1	cv	ORG
admet-2357	90	2	0.04 mol l-1	QUANTITY
admet-2357	90	3	4.0	CARDINAL
admet-2357	91	1	50	CARDINAL
admet-2357	91	2	six	CARDINAL
admet-2357	92	1	50 µg ml-1 avn	QUANTITY
admet-2357	92	2	1b	CARDINAL
admet-2357	94	1	1	CARDINAL
admet-2357	95	1	bdd	ORG
admet-2357	95	2	50 μg ml-1 of	QUANTITY
admet-2357	95	3	4.0	CARDINAL
admet-2357	96	1	100	CARDINAL
admet-2357	96	2	50	CARDINAL
admet-2357	96	3	75	DATE
admet-2357	96	4	100	CARDINAL
admet-2357	96	5	200	CARDINAL
admet-2357	96	6	300	CARDINAL
admet-2357	96	7	400	CARDINAL
admet-2357	99	1	linear	ORG
admet-2357	99	2	linear	ORG
admet-2357	99	3	1/2	CARDINAL
admet-2357	99	4	avn	PERSON
admet-2357	99	5	0.276	CARDINAL
admet-2357	99	6	0.431	CARDINAL
admet-2357	99	7	0.994	CARDINAL
admet-2357	100	1	0.996	CARDINAL
admet-2357	100	2	0.553 log v / mv s−1 0.739	QUANTITY
admet-2357	101	1	2024	CARDINAL
admet-2357	101	2	529	CARDINAL
admet-2357	101	3	avanafil	ORG
admet-2357	101	4	533 0.553	CARDINAL
admet-2357	101	5	1.0	CARDINAL
admet-2357	101	6	0.5	CARDINAL
admet-2357	103	1	47.7/(ep-ep/2	DATE
admet-2357	103	2	77	CARDINAL
admet-2357	105	1	0.5	CARDINAL
admet-2357	105	2	1.24	CARDINAL
admet-2357	105	3	1	CARDINAL
admet-2357	106	1	22	CARDINAL
admet-2357	107	1	avn	PRODUCT
admet-2357	107	2	bdd	ORG
admet-2357	108	1	2.0-12.0	CARDINAL
admet-2357	109	1	2a	CARDINAL
admet-2357	109	2	11.0	CARDINAL
admet-2357	111	1	12.0	CARDINAL
admet-2357	112	1	avn anodic	PERSON
admet-2357	112	2	3.0	CARDINAL
admet-2357	112	3	+ 1.609	CARDINAL
admet-2357	112	4	0.991	CARDINAL
admet-2357	113	1	0.055 v	QUANTITY
admet-2357	113	2	0.059	CARDINAL
admet-2357	113	3	avn	PERSON
admet-2357	114	1	22,23	CARDINAL
admet-2357	115	1	1	CARDINAL
admet-2357	115	2	avn	PERSON
admet-2357	116	1	2b	CARDINAL
admet-2357	117	1	+1.56	PERSON
admet-2357	117	2	1.57	CARDINAL
admet-2357	117	3	1.39	CARDINAL
admet-2357	117	4	1.15	CARDINAL
admet-2357	117	5	0.1	CARDINAL
admet-2357	117	6	pbs	ORG
admet-2357	117	7	2.5	CARDINAL
admet-2357	117	8	7.4	CARDINAL
admet-2357	118	1	1.92	CARDINAL
admet-2357	118	2	1.54	CARDINAL
admet-2357	118	3	2.61	CARDINAL
admet-2357	118	4	0.63	CARDINAL
admet-2357	119	1	2a	CARDINAL
admet-2357	119	2	2b	CARDINAL
admet-2357	120	1	5 μg ml-1 avn	QUANTITY
admet-2357	120	2	2	CARDINAL
admet-2357	122	1	1	CARDINAL
admet-2357	122	2	avn	PERSON
admet-2357	123	1	https://doi.org/10.5599/admet.2357 h. s. ali et al. admet & dmpk 12(3	ORG
admet-2357	123	2	2024	CARDINAL
admet-2357	123	3	529	CARDINAL
admet-2357	124	1	sw voltammograms	PERSON
admet-2357	124	2	bdd	ORG
admet-2357	125	1	50	CARDINAL
admet-2357	125	2	8	CARDINAL
admet-2357	125	3	30	CARDINAL
admet-2357	126	1	two	CARDINAL
admet-2357	126	2	2-11	CARDINAL
admet-2357	126	3	3.0-8.0	CARDINAL
admet-2357	127	1	two	CARDINAL
admet-2357	127	2	dpv	ORG
admet-2357	127	3	avn	ORG
admet-2357	128	1	dpv	ORG
admet-2357	128	2	8.6	CARDINAL
admet-2357	128	3	3	CARDINAL
admet-2357	131	1	one	CARDINAL
admet-2357	132	1	δes	NORP
admet-2357	132	2	8 mv	QUANTITY
admet-2357	132	3	30	CARDINAL
admet-2357	132	4	25	CARDINAL
admet-2357	132	5	150	CARDINAL
admet-2357	134	1	50	CARDINAL
admet-2357	136	1	50	CARDINAL
admet-2357	137	1	30	CARDINAL
admet-2357	137	2	δes= 8 mv	QUANTITY
admet-2357	137	3	50	CARDINAL
admet-2357	139	1	60	CARDINAL
admet-2357	140	1	6	CARDINAL
admet-2357	140	2	50	CARDINAL
admet-2357	140	3	60	CARDINAL
admet-2357	140	4	12	CARDINAL
admet-2357	140	5	12	CARDINAL
admet-2357	141	1	sw	ORG
admet-2357	141	2	more than 12	CARDINAL
admet-2357	143	1	12	CARDINAL
admet-2357	144	1	0.04 mol l-1	QUANTITY
admet-2357	144	2	4.0	CARDINAL
admet-2357	144	3	50	CARDINAL
admet-2357	144	4	12	CARDINAL
admet-2357	144	5	60	CARDINAL
admet-2357	146	1	avn	PERSON
admet-2357	148	1	avn	PERSON
admet-2357	149	1	0.5	CARDINAL
admet-2357	149	2	30.0 μg	QUANTITY
admet-2357	150	1	1.0 to	CARDINAL
admet-2357	151	1	4	CARDINAL
admet-2357	152	1	+1.33	GPE
admet-2357	152	2	avn	PERSON
admet-2357	152	3	0.999	CARDINAL
admet-2357	152	4	10	CARDINAL
admet-2357	153	1	2024	CARDINAL
admet-2357	153	2	529	CARDINAL
admet-2357	153	3	avanafil	ORG
admet-2357	153	4	535	CARDINAL
admet-2357	153	5	3	CARDINAL
admet-2357	154	1	dpv	ORG
admet-2357	154	2	5 5 μg ml-1 avn	CARDINAL
admet-2357	155	1	dpv	ORG
admet-2357	155	2	50	CARDINAL
admet-2357	155	3	8	CARDINAL
admet-2357	155	4	0.05	CARDINAL
admet-2357	155	5	s. swv	PERSON
admet-2357	155	6	50	CARDINAL
admet-2357	155	7	8	CARDINAL
admet-2357	155	8	30	CARDINAL
admet-2357	157	1	0.14 μg ml-1	QUANTITY
admet-2357	158	1	loq	ORG
admet-2357	158	2	0.46 μg ml-1	QUANTITY
admet-2357	159	1	0.95 mol l-1	QUANTITY
admet-2357	160	1	3 s	QUANTITY
admet-2357	161	1	10	CARDINAL
admet-2357	162	1	avn	PERSON
admet-2357	163	1	0.29 mol l-1	QUANTITY
admet-2357	163	2	21	CARDINAL
admet-2357	164	1	22,23	CARDINAL
admet-2357	164	2	1	CARDINAL
admet-2357	165	1	avn	PERSON
admet-2357	166	1	4	CARDINAL
admet-2357	166	2	sw voltammograms	PERSON
admet-2357	166	3	avn	PERSON
admet-2357	166	4	0.5	CARDINAL
admet-2357	166	5	1.0	CARDINAL
admet-2357	166	6	2.5	CARDINAL
admet-2357	166	7	5.0	CARDINAL
admet-2357	166	8	7.5	CARDINAL
admet-2357	166	9	10.0	CARDINAL
admet-2357	166	10	15.0	CARDINAL
admet-2357	166	11	20.0	CARDINAL
admet-2357	166	12	25.0	CARDINAL
admet-2357	166	13	30.0	CARDINAL
admet-2357	167	1	0.04 mol l-1	QUANTITY
admet-2357	168	1	50	CARDINAL
admet-2357	168	2	12	CARDINAL
admet-2357	169	1	60	CARDINAL
admet-2357	169	2	avn	ORG
admet-2357	170	1	https://doi.org/10.5599/admet.2357 h. s. ali et al. admet	PERSON
admet-2357	170	2	2024	CARDINAL
admet-2357	170	3	529	CARDINAL
admet-2357	170	4	542 536	CARDINAL
admet-2357	170	5	1	CARDINAL
admet-2357	171	1	avn zno-nps	PERSON
admet-2357	171	2	2.7–0.33 0.71	QUANTITY
admet-2357	172	1	21	CARDINAL
admet-2357	172	2	nimodipine nio-nps	PERSON
admet-2357	172	3	0.05	CARDINAL
admet-2357	172	4	1.0 0.016	CARDINAL
admet-2357	172	5	22	CARDINAL
admet-2357	172	6	tio2	ORG
admet-2357	172	7	0.01	CARDINAL
admet-2357	172	8	8.0 0.003	CARDINAL
admet-2357	172	9	23	CARDINAL
admet-2357	172	10	1.0	CARDINAL
admet-2357	172	11	62 0.29	CARDINAL
admet-2357	172	12	zno-nps/mwcnt	ORG
admet-2357	172	13	nio-nps/poly(sulf)/pge	ORG
admet-2357	172	14	nio nanostructured/ sulfanilamide polymeric film	PERSON
admet-2357	172	15	tio2	GPE
admet-2357	172	16	days	DATE
admet-2357	173	1	ten	CARDINAL
admet-2357	173	2	0.5	CARDINAL
admet-2357	173	3	a single day	DATE
admet-2357	174	1	5.6 %	PERCENT
admet-2357	175	1	five consecutive business days	DATE
admet-2357	176	1	7.2 %	PERCENT
admet-2357	178	1	5 μg ml-1 avn	QUANTITY
admet-2357	180	1	approximately ±5%	PERCENT
admet-2357	181	1	sodium	PERSON
admet-2357	181	2	10-fold	CARDINAL
admet-2357	182	1	avn	PRODUCT
admet-2357	182	2	10×	CARDINAL
admet-2357	182	3	avn	PERSON
admet-2357	183	1	avn	PERSON
admet-2357	184	1	dop	ORG
admet-2357	184	2	1:1	CARDINAL
admet-2357	184	3	1:5	CARDINAL
admet-2357	184	4	1:10	TIME
admet-2357	184	5	avn	PERSON
admet-2357	185	1	dop	ORG
admet-2357	185	2	avn	PERSON
admet-2357	185	3	5	CARDINAL
admet-2357	187	1	avn	PERSON
admet-2357	190	1	6	CARDINAL
admet-2357	192	1	1 + 0.614	MONEY
admet-2357	193	1	avn	PERSON
admet-2357	193	2	103.2 mg	QUANTITY
admet-2357	193	3	3.8 %	PERCENT
admet-2357	193	4	100.0 mg	QUANTITY
admet-2357	195	1	10 ml	QUANTITY
admet-2357	195	2	standard avn	ORG
admet-2357	195	3	1	CARDINAL
admet-2357	195	4	5	DATE
admet-2357	195	5	10 μg	QUANTITY
admet-2357	195	6	2	CARDINAL
admet-2357	195	7	2	CARDINAL
admet-2357	196	1	2024	CARDINAL
admet-2357	196	2	529	CARDINAL
admet-2357	196	3	avanafil	ORG
admet-2357	196	4	537	CARDINAL
admet-2357	196	5	5	CARDINAL
admet-2357	196	6	sw voltammograms	PERSON
admet-2357	196	7	avn	PERSON
admet-2357	196	8	5.0 μg ml-1	QUANTITY
admet-2357	196	9	5	CARDINAL
admet-2357	196	10	10-fold	CARDINAL
admet-2357	196	11	5	CARDINAL
admet-2357	196	12	10-fold	CARDINAL
admet-2357	196	13	dop	ORG
admet-2357	196	14	5	CARDINAL
admet-2357	196	15	10-fold	CARDINAL
admet-2357	197	1	4	CARDINAL
admet-2357	197	2	6	CARDINAL
admet-2357	198	1	sw voltammograms	ORG
admet-2357	198	2	1.0	CARDINAL
admet-2357	198	3	2.5	CARDINAL
admet-2357	198	4	5.0	CARDINAL
admet-2357	198	5	10.0	CARDINAL
admet-2357	198	6	15.0	CARDINAL
admet-2357	198	7	20.0 μg ml-1 avn	QUANTITY
admet-2357	198	8	0.04 mol l-1	QUANTITY
admet-2357	198	9	4.0	CARDINAL
admet-2357	199	1	bdd	ORG
admet-2357	201	1	4	CARDINAL
admet-2357	201	2	h. s. ali et al	PERSON
admet-2357	201	3	2024	CARDINAL
admet-2357	201	4	529	CARDINAL
admet-2357	201	5	542 538	CARDINAL
admet-2357	201	6	2	CARDINAL
admet-2357	201	7	avn	PERSON
admet-2357	201	8	±	CARDINAL
admet-2357	201	9	0	CARDINAL
admet-2357	201	10	1.03	CARDINAL
admet-2357	201	11	2.03	CARDINAL
admet-2357	201	12	11.03	CARDINAL
admet-2357	201	13	three	CARDINAL
admet-2357	202	1	0.1	CARDINAL
admet-2357	202	2	mol l-1 hcl	PERSON
admet-2357	202	3	7	CARDINAL
admet-2357	203	1	1.0	CARDINAL
admet-2357	203	2	20.0	CARDINAL
admet-2357	204	1	2.1	CARDINAL
admet-2357	204	2	245	CARDINAL
admet-2357	205	1	0.082	CARDINAL
admet-2357	206	1	0.998	CARDINAL
admet-2357	206	2	6	CARDINAL
admet-2357	207	1	avn	ORG
admet-2357	208	1	three	CARDINAL
admet-2357	208	2	avn	PERSON
admet-2357	208	3	101.5 mg	QUANTITY
admet-2357	208	4	1.4 %	PERCENT
admet-2357	209	1	avn	PERSON
admet-2357	211	1	two	CARDINAL
admet-2357	211	2	2.32	CARDINAL
admet-2357	211	3	95 %	PERCENT
admet-2357	211	4	one	CARDINAL
admet-2357	211	5	2.78	CARDINAL
admet-2357	211	6	0.05	CARDINAL
admet-2357	212	1	7	CARDINAL
admet-2357	213	1	10 μg ml-1 avn	QUANTITY
admet-2357	213	2	0.1	CARDINAL
admet-2357	213	3	mol l-1 hcl	PERSON
admet-2357	213	4	1 cm	QUANTITY
admet-2357	214	1	8	CARDINAL
admet-2357	214	2	0.5 μg	CARDINAL
admet-2357	216	1	0.681 c /	MONEY
admet-2357	217	1	0.997	CARDINAL
admet-2357	217	2	8	CARDINAL
admet-2357	219	1	3	CARDINAL
admet-2357	220	1	2024	CARDINAL
admet-2357	220	2	529	CARDINAL
admet-2357	220	3	avanafil	ORG
admet-2357	220	4	539	CARDINAL
admet-2357	220	5	8	CARDINAL
admet-2357	221	1	sw voltammograms	PERSON
admet-2357	221	2	0.5 μg ml-1 avn	QUANTITY
admet-2357	221	3	1-5	CARDINAL
admet-2357	221	4	2.5	CARDINAL
admet-2357	221	5	5.0	CARDINAL
admet-2357	221	6	7.5	CARDINAL
admet-2357	221	7	10.0	CARDINAL
admet-2357	221	8	15.0	CARDINAL
admet-2357	221	9	ml−1 avn	PERSON
admet-2357	221	10	4.0	CARDINAL
admet-2357	223	1	4	CARDINAL
admet-2357	224	1	3	CARDINAL
admet-2357	226	1	±	CARDINAL
admet-2357	226	2	0.50	CARDINAL
admet-2357	226	3	92.0	CARDINAL
admet-2357	227	1	avn	PERSON
admet-2357	228	1	avn	PERSON
admet-2357	232	1	avn	PERSON
admet-2357	235	1	1	CARDINAL
admet-2357	235	2	r. shamloul	PERSON
admet-2357	235	3	h. ghanem	PERSON
admet-2357	237	1	381	CARDINAL
admet-2357	237	2	2013	DATE
admet-2357	237	3	153	CARDINAL
admet-2357	238	1	2	CARDINAL
admet-2357	238	2	burnett	PERSON
admet-2357	240	1	75	CARDINAL
admet-2357	241	1	https://doi.org/10.5599/admet.2357 https://doi.org/10.1016/s0140-6736(12)60520-0	ORG
admet-2357	241	2	h. s. ali et al	PERSON
admet-2357	241	3	2024	CARDINAL
admet-2357	241	4	529-542 540	QUANTITY
admet-2357	241	5	3	CARDINAL
admet-2357	241	6	m.n.	GPE
admet-2357	241	7	abou-omar	PERSON
admet-2357	241	8	n.m. el zahar	GPE
admet-2357	241	9	youssef	PERSON
admet-2357	241	10	m.a. amin	PERSON
admet-2357	241	11	m.s. attia	PERSON
admet-2357	241	12	e.h. mohamed.	PERSON
admet-2357	242	1	avanafil	ORG
admet-2357	243	1	rsc advances 11	PERSON
admet-2357	243	2	2021	CARDINAL
admet-2357	243	3	29797-29806	DATE
admet-2357	244	1	https://doi.org/10.1039/d1ra05492a	ORG
admet-2357	245	1	4	CARDINAL
admet-2357	245	2	burke, j.d. evans	ORG
admet-2357	245	3	avanafil	ORG
admet-2357	246	1	1	CARDINAL
admet-2357	246	2	2012	DATE
admet-2357	246	3	517	CARDINAL
admet-2357	248	1	5	CARDINAL
admet-2357	248	2	a.z.g.a	CARDINAL
admet-2357	248	3	m.h. alyami	GPE
admet-2357	248	4	n.g. eissa	ORG
admet-2357	248	5	balata	ORG
admet-2357	249	1	nahas	PERSON
admet-2357	250	1	doxazosin mesylate:	ORG
admet-2357	251	1	12	CARDINAL
admet-2357	251	2	2024	CARDINAL
admet-2357	251	3	167	CARDINAL
admet-2357	253	1	6	CARDINAL
admet-2357	253	2	g. corona	PERSON
admet-2357	253	3	g. rastrelli	PERSON
admet-2357	253	4	a. burri	PERSON
admet-2357	253	5	e.a.	GPE
admet-2357	253	6	jannini	PERSON
admet-2357	253	7	m. maggi	PERSON
admet-2357	254	1	avanafil	ORG
admet-2357	254	2	2nd	ORDINAL
admet-2357	255	1	15	CARDINAL
admet-2357	255	2	237	CARDINAL
admet-2357	256	1	7	CARDINAL
admet-2357	256	2	ibrahim	PERSON
admet-2357	256	3	m.m.	PERSON
admet-2357	258	1	international journal of pharmaceutics	ORG
admet-2357	258	2	517	CARDINAL
admet-2357	258	3	2017	CARDINAL
admet-2357	258	4	148	CARDINAL
admet-2357	260	1	a. akash	PERSON
admet-2357	260	2	v. munipalli	PERSON
admet-2357	260	3	r.m.	ORG
admet-2357	260	4	singh	GPE
admet-2357	260	5	s. nayak	PERSON
admet-2357	260	6	b. vaidhun	PERSON
admet-2357	261	1	avanafil	ORG
admet-2357	262	1	1(1	CARDINAL
admet-2357	262	2	2020	DATE
admet-2357	262	3	29	CARDINAL
admet-2357	263	1	https://scholar.google.com/scholar_url?url=https://www.academia.edu/download/64740720/avana	ORG
admet-2357	263	2	fil_in_tablet_dosage_form.pdf&hl=en&sa	PERSON
admet-2357	263	3	wf2xo5ni7fkaecpsdw&oi	PERSON
admet-2357	263	4	scholarr	PERSON
admet-2357	263	5	9	CARDINAL
admet-2357	263	6	m. hegazy	PERSON
admet-2357	263	7	a. kessiba	PERSON
admet-2357	263	8	m. abdelkawy	PERSON
admet-2357	263	9	a.e.	GPE
admet-2357	264	1	avanafil	ORG
admet-2357	265	1	38	DATE
admet-2357	265	2	2015	CARDINAL
admet-2357	265	3	1660	CARDINAL
admet-2357	267	1	10	CARDINAL
admet-2357	267	2	n. kumar	PERSON
admet-2357	267	3	d. sangeetha	PERSON
admet-2357	267	4	l. kalyanraman	PERSON
admet-2357	267	5	k. sainath	PERSON
admet-2357	268	1	avanafil	ORG
admet-2357	269	1	30	CARDINAL
admet-2357	269	2	2018	DATE
admet-2357	269	3	158	CARDINAL
admet-2357	270	1	11	CARDINAL
admet-2357	270	2	m. zhao	PERSON
admet-2357	270	3	x. wu	PERSON
admet-2357	270	4	z. yu	PERSON
admet-2357	270	5	z. liu	PERSON
admet-2357	270	6	j. yuan	PERSON
admet-2357	270	7	h. liu	PERSON
admet-2357	270	8	y. jin	PERSON
admet-2357	272	1	rsc advances 12	PERSON
admet-2357	272	2	2022	CARDINAL
admet-2357	272	3	9256-9262	DATE
admet-2357	274	1	12	CARDINAL
admet-2357	274	2	k.l.	GPE
admet-2357	274	3	e.d. patel	GPE
admet-2357	274	4	prajapati	PERSON
admet-2357	274	5	r.n. patel	PERSON
admet-2357	274	6	y.k.	GPE
admet-2357	274	7	patel	PERSON
admet-2357	275	1	avanafil	ORG
admet-2357	276	1	4 (	PERCENT
admet-2357	276	2	2017	CARDINAL
admet-2357	276	3	171	CARDINAL
admet-2357	278	1	13	CARDINAL
admet-2357	278	2	lee	PERSON
admet-2357	278	3	o.r. park	PERSON
admet-2357	278	4	y.j	GPE
admet-2357	278	5	yang	PERSON
admet-2357	278	6	han	NORP
admet-2357	278	7	jung	GPE
admet-2357	278	8	kim	PERSON
admet-2357	278	9	s.y.	PERSON
admet-2357	279	1	94	CARDINAL
admet-2357	279	2	journal	PERSON
admet-2357	279	3	60	CARDINAL
admet-2357	279	4	2022	CARDINAL
admet-2357	279	5	953	CARDINAL
admet-2357	281	1	14	CARDINAL
admet-2357	281	2	patel	PERSON
admet-2357	281	3	c.s. kothari	PERSON
admet-2357	281	4	avanafil	ORG
admet-2357	282	1	journal of aoac international	ORG
admet-2357	282	2	99	CARDINAL
admet-2357	282	3	2016	CARDINAL
admet-2357	282	4	649	CARDINAL
admet-2357	284	1	15	CARDINAL
admet-2357	284	2	j. jung	PERSON
admet-2357	284	3	s. choi	PERSON
admet-2357	284	4	s.h. cho	PERSON
admet-2357	284	5	j.l.	GPE
admet-2357	284	6	a. hwang	PERSON
admet-2357	284	7	kim	PERSON
admet-2357	284	8	b.s. kim	PERSON
admet-2357	284	9	a. koguchi	PERSON
admet-2357	284	10	s. miyoshi	PERSON
admet-2357	284	11	h. okabe	PERSON
admet-2357	284	12	k.s.	GPE
admet-2357	284	13	bae	ORG
admet-2357	284	14	avanafil	ORG
admet-2357	284	15	5	CARDINAL
admet-2357	284	16	korean	NORP
admet-2357	285	1	32	DATE
admet-2357	285	2	2010	DATE
admet-2357	285	3	1178-1187	CARDINAL
admet-2357	286	1	https://doi.org/10.1016/j.clinthera.2010.06.011	ORG
admet-2357	286	2	16	CARDINAL
admet-2357	286	3	m.n.	GPE
admet-2357	286	4	abou-omar	PERSON
admet-2357	286	5	n.m. el zahar	GPE
admet-2357	286	6	youssef	PERSON
admet-2357	286	7	m.a. amin	PERSON
admet-2357	286	8	m.s. attia	PERSON
admet-2357	286	9	e.h. mohamed.	PERSON
admet-2357	287	1	avanafil	ORG
admet-2357	287	2	https://doi.org/10.1039/d1ra05492a	ORG
admet-2357	288	1	2024	CARDINAL
admet-2357	288	2	529	CARDINAL
admet-2357	288	3	avanafil	ORG
admet-2357	288	4	541	CARDINAL
admet-2357	289	1	rsc advances 11	PERSON
admet-2357	289	2	2021	CARDINAL
admet-2357	289	3	29797-29806	DATE
admet-2357	290	1	https://doi.org/10.1039/d1ra05492a	ORG
admet-2357	290	2	17	CARDINAL
admet-2357	290	3	e. akkaya	PERSON
admet-2357	290	4	b. özbek	PERSON
admet-2357	290	5	s. bakırdere	PERSON
admet-2357	291	1	avanafil	ORG
admet-2357	291	2	microchemical	PERSON
admet-2357	291	3	147	CARDINAL
admet-2357	291	4	2019	CARDINAL
admet-2357	291	5	269	CARDINAL
admet-2357	293	1	18	CARDINAL
admet-2357	293	2	kammoun	GPE
admet-2357	293	3	a. khedr	PERSON
admet-2357	293	4	o.a. ahmed.	PERSON
admet-2357	294	1	avanafil	ORG
admet-2357	295	1	rsc advances 10 (2020) 9407-9413	ORG
admet-2357	296	1	19	CARDINAL
admet-2357	296	2	ibrahim	PERSON
admet-2357	296	3	h. hashem	PERSON
admet-2357	296	4	m. elhenawee	PERSON
admet-2357	296	5	h. saleh	PERSON
admet-2357	297	1	avanafil	ORG
admet-2357	298	1	rsc advances 10 (2020)	ORG
admet-2357	298	2	1379	CARDINAL
admet-2357	299	1	20	CARDINAL
admet-2357	299	2	b. özbek	PERSON
admet-2357	299	3	s. bakırdere	PERSON
admet-2357	300	1	quadrupole‐tof‐ms	PERSON
admet-2357	301	1	42	CARDINAL
admet-2357	301	2	2019	CARDINAL
admet-2357	301	3	475	CARDINAL
admet-2357	303	1	m.b. ali	PERSON
admet-2357	303	2	abdel-raoof	PERSON
admet-2357	303	3	h.a. hendawy	GPE
admet-2357	303	4	w. talaat	PERSON
admet-2357	303	5	g.a. omran	PERSON
admet-2357	303	6	s. morshedy	PERSON
admet-2357	305	1	168	CARDINAL
admet-2357	305	2	2021) 087510	DATE
admet-2357	307	1	22	CARDINAL
admet-2357	307	2	ali	PERSON
admet-2357	307	3	abdel-aal	PERSON
admet-2357	307	4	a.h. rageh	GPE
admet-2357	307	5	mohamed	PERSON
admet-2357	308	1	nio	PERSON
admet-2357	308	2	avanafil	ORG
admet-2357	309	1	microchemical	ORG
admet-2357	309	2	172	CARDINAL
admet-2357	309	3	2022	CARDINAL
admet-2357	309	4	106895	DATE
admet-2357	311	1	ali	PERSON
admet-2357	311	2	a.h. rageh	GPE
admet-2357	311	3	abdel-aal	PERSON
admet-2357	311	4	mohamed	PERSON
admet-2357	312	1	avanafil	ORG
admet-2357	313	1	microchemical	PERSON
admet-2357	313	2	185	CARDINAL
admet-2357	313	3	2023	CARDINAL
admet-2357	313	4	108261	DATE
admet-2357	314	1	24	CARDINAL
admet-2357	314	2	k. peckova	PERSON
admet-2357	314	3	j. musilova	PERSON
admet-2357	314	4	j. barek	PERSON
admet-2357	315	1	3	CARDINAL
admet-2357	315	2	2009	DATE
admet-2357	315	3	148e172	CARDINAL
admet-2357	317	1	25	CARDINAL
admet-2357	317	2	m. yence	PERSON
admet-2357	317	3	g. cetinkaya	PERSON
admet-2357	317	4	j. ozcelikay	PERSON
admet-2357	317	5	s.i. kaya	PERSON
admet-2357	317	6	s.a.	GPE
admet-2357	319	1	52	CARDINAL
admet-2357	319	2	2022	CARDINAL
admet-2357	319	3	1122	CARDINAL
admet-2357	320	1	26	CARDINAL
admet-2357	320	2	n. yang	PERSON
admet-2357	320	3	j.s.	PERSON
admet-2357	320	4	foord	ORDINAL
admet-2357	320	5	x. jiang	PERSON
admet-2357	322	1	99	CARDINAL
admet-2357	322	2	2016	CARDINAL
admet-2357	322	3	90e110	CARDINAL
admet-2357	324	1	27	CARDINAL
admet-2357	324	2	cobb	GPE
admet-2357	324	3	z.j	DATE
admet-2357	324	4	j.v.	PERSON
admet-2357	325	1	the twenty-first century	DATE
admet-2357	326	1	annual	DATE
admet-2357	326	2	11	CARDINAL
admet-2357	326	3	2018	DATE
admet-2357	326	4	463	CARDINAL
admet-2357	328	1	28	CARDINAL
admet-2357	328	2	k. muzyka	PERSON
admet-2357	328	3	j. sun	PERSON
admet-2357	328	4	t.h. fereja	ORG
admet-2357	328	5	w. zhang	PERSON
admet-2357	328	6	g. xu	PERSON
admet-2357	330	1	11	CARDINAL
admet-2357	332	1	29	CARDINAL
admet-2357	332	2	lourencao	GPE
admet-2357	332	3	r.f. brocenschi	GPE
admet-2357	332	4	r.a. medeiros	PERSON
admet-2357	332	5	o. fatibello-filho	PERSON
admet-2357	332	6	r.c. rocha-	PERSON
admet-2357	332	7	filho	PERSON
admet-2357	335	1	1291e1311	CARDINAL
admet-2357	336	1	30	CARDINAL
admet-2357	336	2	a. meoipun	PERSON
admet-2357	336	3	k. kaewjua	PERSON
admet-2357	336	4	o. chailapakul	PERSON
admet-2357	336	5	w. siangproh	PERSON
admet-2357	338	1	11	CARDINAL
admet-2357	338	2	2023	CARDINAL
admet-2357	338	3	303	CARDINAL
admet-2357	339	1	https://doi.org/10.1016/j.microc.2021.106895 https://doi.org/10.1016/j.microc.2022.108261 https://doi.org/10.1080/10408340903011812	PERSON
admet-2357	340	1	h. s. ali et al	PERSON
admet-2357	340	2	2024	CARDINAL
admet-2357	340	3	529-542 542	QUANTITY
admet-2357	340	4	31	CARDINAL
admet-2357	340	5	n. khadhri	PERSON
admet-2357	340	6	m.b. mosbah	PERSON
admet-2357	340	7	n. rabaaoui	PERSON
admet-2357	340	8	m.a. khadimallah	PERSON
admet-2357	341	1	bdd	ORG
admet-2357	341	2	one	CARDINAL
admet-2357	342	1	iranian	NORP
admet-2357	342	2	40	CARDINAL
admet-2357	342	3	2021	CARDINAL
admet-2357	342	4	1446	CARDINAL
admet-2357	343	1	32	CARDINAL
admet-2357	343	2	švorc	ORG
admet-2357	343	3	d. m. stanković	PERSON
admet-2357	343	4	e. mehmeti	PERSON
admet-2357	343	5	k. kalcher	PERSON
admet-2357	345	1	6	CARDINAL
admet-2357	345	2	4853-4859	DATE
admet-2357	347	1	33	CARDINAL
admet-2357	347	2	k. cinková	PERSON
admet-2357	347	3	k. kianičková	PERSON
admet-2357	347	4	d. m. stanković	PERSON
admet-2357	347	5	m. vojs	PERSON
admet-2357	347	6	m. marton	PERSON
admet-2357	349	1	10	CARDINAL
admet-2357	349	2	991	CARDINAL
admet-2357	350	1	34	CARDINAL
admet-2357	350	2	l. dubenska	PERSON
admet-2357	350	3	l. svorc	PERSON
admet-2357	351	1	first	ORDINAL
admet-2357	352	1	858	CARDINAL
admet-2357	352	2	2020) 113759	DATE
admet-2357	353	1	https://doi.org/10.1016/j.jelechem.2019.113759	CARDINAL
admet-2357	353	2	35	CARDINAL
admet-2357	353	3	ali	PERSON
admet-2357	355	1	441	CARDINAL
admet-2357	355	2	2024) 138262	DATE
admet-2357	356	1	36	CARDINAL
admet-2357	356	2	barzani	GPE
admet-2357	356	3	h.s. ali	GPE
admet-2357	356	4	o. yunusoğlu	PERSON
admet-2357	358	1	144	CARDINAL
admet-2357	358	2	2024) 110932	DATE
admet-2357	359	1	37	CARDINAL
admet-2357	359	2	pınar	PERSON
admet-2357	359	3	h.a. barzani	GPE
admet-2357	359	4	h.s. ali	GPE
admet-2357	361	1	monatshefte für	PERSON
admet-2357	361	2	monthly 154	DATE
admet-2357	361	3	2023	CARDINAL
admet-2357	363	1	38	CARDINAL
admet-2357	363	2	s. allahverdiyeva	PERSON
admet-2357	363	3	e. keskin	PERSON
admet-2357	363	4	o. yunusoğlu	PERSON
admet-2357	363	5	y. yardım	PERSON
admet-2357	363	6	z. şentürk	PERSON
admet-2357	364	1	108	CARDINAL
admet-2357	364	2	2020) 107962	DATE
admet-2357	365	1	2024	CARDINAL
admet-2357	365	2	iapc	ORG
admet-2357	365	3	zagreb	GPE
admet-2357	365	4	croatia	GPE
admet-2357	366	1	http://creativecommons.org/licenses/by/3.0/	ORG
admet-2357	367	1	https://doi.org/10.30492/ijcce.2020.39880	NORP
admet-2357	367	2	https://doi.org/10.1016/j.jelechem.2019.113759 https://doi.org/10.1016/j.foodchem.2023.138262 https://doi.org/10.1016/j.diamond.2024.110932	GPE
admet-2357	367	3	https://doi.org/10.1007/s00706-023-03126-8	GPE
admet-2357	367	4	http://creativecommons.org/licenses/by/3.0/	PERSON